Abstract 1857: Development of monoclonal antibodies against CD44v specifically expressed in cancers

作者
Yukinari Kato,Hiroyuki Suzuki,Mika Kato Kaneko
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 1857-1857
标识
DOI:10.1158/1538-7445.am2024-1857
摘要

Abstract CD44 is a transmembrane glycoprotein that binds to the extracellular matrix including hyaluronic acid. Human CD44 has 19 exons, 10 of which are commonly present in all isoforms. CD44 standard isoform (CD44s) is composed of the common exons, and is expressed in many cell types. CD44 variants (CD44v) are produced by alternative splicing, in which the remaining nine variant exons are inserted into the CD44 standard isoform in various combinations. The CD44 isoforms have overlapping and unique functions. Both CD44s and CD44v harbor hyaluronan-binding motifs that promote interaction with the tumor microenvironment, which activate various signaling pathways in tumor cells. CD44v is mainly expressed in epithelial cells and is involved in cell adhesion, proliferation, and survival. Overexpression of CD44v is observed in many solid tumors and plays an important role in invasion, metastasis, and acquisition of stemness. In this study, we employed the Cell-Based Immunization and Screening method (CBIS method), and established highly sensitive anti-CD44 monoclonal antibodies (mAbs) using CD44v3-10-overexpressed cell lines as immunogens. After that, we determined the epitopes by enzyme-linked immunosorbent assay and investigated their applications. As a result, we successfully established eight mAbs against each CD44v (v3 to v10), which can be used for flow cytometry, western blotting, and immunohistochemistry. Furthermore, some of them exhibited cancer specificity against pancreatic cancers, colorectal cancers, gastric cancers, or oral cancers, indicating that established anti-CD44v mAbs are useful for the antibody therapies. Citation Format: Yukinari Kato, Hiroyuki Suzuki, Mika K. Kaneko. Development of monoclonal antibodies against CD44v specifically expressed in cancers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 1857.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
王钰绮完成签到,获得积分10
刚刚
风兮发布了新的文献求助10
刚刚
xxwang完成签到,获得积分20
刚刚
刚刚
JamesPei的应助被大意的凝芙采纳,获得20
刚刚
踏实白梦完成签到,获得积分10
1秒前
英俊冷风发布了新的文献求助10
2秒前
mm发布了新的文献求助10
2秒前
是小叮当完成签到 ,获得积分10
2秒前
Hello的应助被金三顺采纳,获得10
2秒前
领导范儿的应助被xxwang采纳,获得10
3秒前
科研通AI6.4的应助被Royal采纳,获得10
3秒前
深情安青的应助被风中的宛白采纳,获得10
3秒前
4秒前
青青草原青草蛋糕完成签到 ,获得积分10
4秒前
zsn完成签到,获得积分10
5秒前
纯真的滑板完成签到,获得积分10
5秒前
噜噜噜发布了新的文献求助10
5秒前
fengling完成签到,获得积分10
5秒前
Tessa完成签到,获得积分10
7秒前
7秒前
神经蛙发布了新的文献求助60
9秒前
能不能给我来篇SSCI完成签到,获得积分10
9秒前
9秒前
9秒前
研友_8KXdRL发布了新的文献求助10
9秒前
小蘑菇的应助被聪慧远山采纳,获得10
10秒前
Lili完成签到 ,获得积分10
10秒前
Furmark_14完成签到,获得积分10
10秒前
10秒前
落后曲奇完成签到,获得积分10
11秒前
好运丫丫耶完成签到,获得积分10
11秒前
11秒前
大个的应助被trx采纳,获得10
11秒前
11秒前
Jack完成签到,获得积分10
12秒前
阿白发布了新的文献求助10
12秒前
CipherSage的应助被鱼七采纳,获得10
12秒前
YIDAN发布了新的文献求助20
13秒前
楚鹏宇发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181408
求助须知:如何正确求助?哪些是违规求助? 9571330
关于积分的说明 21817615
捐赠科研通 7777856
什么是DOI,文献DOI怎么找? 3433479
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479527